Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cancer incidence and lifespan vs. alpha-particle dose in beagles

Journal Article · · Health Phys.; (United States)
Young adult beagles were injected with graded activities of /sup 239/Pu, /sup 241/Am, /sup 228/Th, /sup 228/Ra or /sup 226/Ra and observed throughout their lifespans. The vast majority of the dose was from alpha particles. The lifetime incidence of bone sarcoma increased with average skeletal dose, more or less linearly up to high incidence for /sup 239/Pu, /sup 241/Am, /sup 228/Th and /sup 226/Ra, but sigmoid fashion for /sup 228/Ra. Based on average skeletal dose, the toxicity of the emitters relative to /sup 226/Ra = 1.0 was /sup 239/Pu = 16.6 +/- 4.5, /sup 241/Am = 5.4 +/- 1.6, /sup 228/Th = 8.5 +/- 2.3 and /sup 228/Ra = 2.0 +/- 0.5. At the lowest doses, the average lifespans were 97% +/- 3% of that in the controls. If beneficial effects occurred, they may have been overwhelmed by the destructiveness of the densely ionizing alpha particles. A cell nucleus 5 micron in diameter receives a mean dose of about 1 Gy (100 rad) when traversed by a single alpha particle. We found no evidence that alpha-particle doses suppressed cancer or lengthened lifespan in beagles.
Research Organization:
Univ. of Utah, Salt Lake City
OSTI ID:
6327127
Journal Information:
Health Phys.; (United States), Journal Name: Health Phys.; (United States) Vol. 5; ISSN HLTPA
Country of Publication:
United States
Language:
English